ANANDA PHARMACY

  Declaration:  Each applicant, at the time of making an application for registration under the provisions of the Act, shall be provided a copy of the declaration as specified in Appendix I along with copies of Code of Pharmaceutical Ethics and Pharmacist’s oath by the state pharmacy council, who shall submit it duly signed. *Privileges of persons registered as a pharmacist on the register of State Pharmacy Council:   Subject to the conditions and restrictions laid down in these Regulations regarding practice of profession of pharmacy by persons possessing approved pharmacy qualifications, every person whose name is for the time being entered in the register of the state in which he is for the time being residing or carrying on his profession or business of pharmacy shall be entitled to practice as “Registered Pharmacist” and engage in the practice of profession of pharmacy and to recover in due course of law in respect of such practice of pharmacy any expenses,...

Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 (Published in Part III, Section 4 of the Gazette of India, dated 6th April, 2002) MEDICAL COUNCIL OF INDIA NOTIFICATION New Delhi, dated 11th March, 2002 No. MCI-211(2)/2001/Registration.  In exercise of the powers conferred under section 20A read with section 33(m) of the Indian Medical Council Act, 1956 (102 of 1956), the Medical Council of India, with the previous approval of the Central Government, hereby makes the following regulations relating to the Professional Conduct, Etiquette and Ethics for registered medical practitioners, namely:- Short Title and Commencement: (1) These Regulations may be called the Indian Medical Council (Professional conduct, Etiquette and Ethics)  Regulations, 2002. (2)They shall come into force on the date of their publication in the Official Gazette.  CHAPTER I  1. CODE OF MEDICAL ETHICS  A. Declaration : Each applicant, at the time of makin...

A PHONE CONVERSATION                                                                                                        DOCTOR : HELLO PAHRMACIST : HELLO SIR. DOCTOR : I WOULD LIKE TO RECOMMEND MY PATIENT TO GIVE HIM A PAN D CAPSULE AND RANIDOM O SYRUP . PHARMACIST : YES SIR ,WE HAVE THE PAN D CAPSULE BUT WE DON'T HAVE THE SAME BRAND AS OF RANIDOM O SYRUP,CAN YOU PLEASE SUGGEST THE COMPOSITION SO THAT WE CAN SUBSTITUTE THE BRAND . DOCTOR : OK THEN I DON'T KNOW THE EXACT COMPOSITION OF THE BRAND CORRECTLY, YOU CAN GIVE HIM SUCRAFIL SYRUP. PHARMACIST : OK SIR THEN I WILL GIVE HIM THE PAN D CAPSULE AND SUCRAFIL SYRUP.HMMM....BUT AS I CHECKED THE COMPOSITION OF THE RANIDOM O AND SUCRALFATE ARE NOT MATCHING CAN I SUBSTITUTE AN E...

GENERIC NAME : ERYTHROMYCIN "BRANDS ARE JUST A NAME NOT THE QUALITY IN CASE OF MEDICINE " . IF THE DRUG IS PRESCRIBED IN A NEAT MANNER THAT A PHARMACIST CAN EASILY UNDERSTAND AND DELIVER THE DRUG IN APPROPRIATE TO THE PRESCRIPTION  ADVANTAGES OF GENERIC NAME PRESCRIBING: 1. UNETHICAL MARKETING WOULD BE STOPPED. 2. CORRECT DOSE TO THE PATIENT WOULD BE GIVEN . 3. EXPIRY OF DRUGS WILL BE LESS AND WASTAGE OF DRUGS WILL BE LESS. 4. COST EFFECTIVE. 5. CORRECT TREATMENT WOULD BE PROVIDED RATHER THE UNETHICAL OFFERINGS PRESCRIPTION WRITTEN BY THE CORPORATE SOCIETY. 6.LESS CONFUSION. 7. STRONG RELATIONSHIP BETWEEN DOCTORS-PATIENT-PHARMACIST. 8. GETTING FREE TIME TO GAIN KNOWLEDGE FROM A JOURNAL WITHOUT SPENDING TIME WITH REPRESENTATIVES HEARING THE SAME LOOP EVERY WEAK OR EVERY DAY. 9. IMPROVE PATIENT COMPLIANCE . 10. PRACTICE OF WRITING RATIONAL PRESCRIPTION. 11. STOPPING THE DRUG ABUSE. 12.QUALITY BLAME WOULD BE IN THE HANDS OF PHARMACIST. 13.RECORDS OF THE DRUG WOULD BE KEPT PROPE...

DRUG NAME  : ERYTHROMYCIN BACTERIAL RESISTANCE CLASS OF DRUG   :MACROLIDES. FOUNDED YEAR  : 1952 ISOLATED FROM:  STREPTOMYCES ERYTHREUS. MECHANISM OF ACTION :  BLOCKS 50S RIBOSOMES -INHIBITS THE PROTEIN SYNTHESIS  - BACTERICIDAL ACTIVITY. Macrolide antibiotics are bacteriostatic agents that inhibit protein synthesis by binding reversibly to the 50S ribosomal subunits of sensitive organisms. Erythromycin appears to inhibit the translocation step such that the nascent peptide chain temporarily residing at the A site fails to move to the P, or donor, site. Alternatively, macrolides may bind and cause a conformational change that terminates protein synthesis by indirectly interfering with transpeptidation and translocation   ANTIMICROBIAL SPECTRUM: streptococcus pyogenes streptococcus pneumoniae niseria gonorrhoeae clodtridia clostridium diphtheria clostridium listera campylobacter legionella branhamella catarrhalis gardnerella vaginallis mycoplasma Helico...